American Vanguard Q3 EPS $0.23 (+27.8% YoY); adj. EBITDA view ~$80M

AMERICAN VANGUARD CORP

2022-Q3 EPS reported $0.78 revenue$449,636,000

Q3 net sales $152M (+3.4% YoY), net income $6.7M (+21.8%), diluted EPS $0.23.
Nine-month net sales $450M (+13.1%), net income $23.5M (+71.5%), EPS $0.78.
Full-year adj. EBITDA target ~$80M (13% of expected sales), exceeding prior 24-28% growth range.
Repurchased 1.5M shares YTD via ASR and 10b5-1 plan.
Secured Counter nematicide registration for soybeans in Brazil; alliance with NewLeaf Symbiotics.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

AMERICAN VANGUARD CORP reported preliminary financial results for the three- and nine-month periods ended September 30, 2022.

Period: the three- and nine-month periods ended September 30, 2022
Result: preliminary results

Exact text from the filing

On November 8, 2022, American Vanguard Corporation (“Registrant”) issued a press release announcing its preliminary, unaudited financial results for the three- and nine-month periods ended September 30, 2022.

View on SEC.gov

Browse all earnings releases →

AMERICAN VANGUARD CORP filing history →

Source: SEC EDGAR

accession 0001193125-22-282425

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.